In the GSE39582 validation set, C2CD4A, PLIN4, RPRM, and APLP1 were more highly expressed in the CRC samples than in the control samples, while the remaining six genes showed the opposite pattern (Fig. 4C). This evidence concerns the gene APLP1 and colorectal carcinoma.